Galmed Pharmaceuticals Now Covered by StockNews.com

GLMD Stock  USD 2.82  0.06  2.08%   
About 57% of Galmed Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Galmed Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Galmed Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Galmed Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
StockNews.com assumed coverage on shares of Galmed Pharmaceuticals in a research note published on Wednesday morning. The firm issued a sell rating on the biopharmaceutical companys stock. Galmed Pharmaceuticals Stock Down 4.7 percent NASDAQ GLMD opened at 0.71 on Wednesday. Galmed Pharmaceuticals has a one year low of 0.29 and a

Read at thelincolnianonline.com
news
  

Galmed Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Galmed Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Galmed Pharmaceuticals Fundamental Analysis

We analyze Galmed Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Galmed Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Galmed Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

Galmed Pharmaceuticals is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Galmed Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Galmed Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Galmed Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Galmed Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Galmed Pharmaceuticals Related Equities

APTOAptose Biosciences   5.56   
0%
64.0%
MBIOMustang Bio   5.26   
0%
60.0%
LPTXLeap Therapeutics   4.43   
0%
51.0%
ADAPAdaptimmune Therapeutics   3.23   
0%
37.0%
FBIOPFortress Biotech   0.29   
0%
3.0%
ABEOAbeona Therapeutics   1.66   
19.0%
0%
PIRSPieris Pharmaceuticals   2.35   
27.0%
0%
ACHLAchilles Therapeutics   2.86   
33.0%
0%
MREOMereo BioPharma   3.12   
36.0%
0%
FBIOFortress Biotech   3.40   
39.0%
0%
ADVMAdverum Biotechnologies   3.54   
40.0%
0%
AFMDAffimed NV   3.54   
40.0%
0%
AKBAAkebia Ther   5.21   
60.0%
0%
KODKodiak Sciences   6.38   
73.0%
0%
PDSBPDS Biotechnology   8.65   
100.0%
0%

Complementary Tools for Galmed Stock analysis

When running Galmed Pharmaceuticals' price analysis, check to measure Galmed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galmed Pharmaceuticals is operating at the current time. Most of Galmed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Galmed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galmed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Galmed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world